Description

Moxifloxacin 400mg infusion Suppliers in India - Intralife

Moxibate Infusion by Intra Life contains Moxifloxacin Hydrochloride equivalent to Moxifloxacin 400 mg in 100 ml, supplied as a ready-to-use intravenous infusion.

Moxifloxacin is a fluoroquinolone antibacterial agent with activity against susceptible bacteria. It acts by inhibiting bacterial enzymes essential for DNA replication, transcription and repair.

The IV formulation is intended for professional healthcare settings where parenteral antibacterial treatment with moxifloxacin is clinically appropriate.

Which Segment Does Moxibate Belong To?

Primary segment: Antibacterial / Antibiotic

Pharmacological class: Fluoroquinolone antibiotic

Secondary segments: Anti-infective, hospital injectable, critical care, respiratory medicine, internal medicine and institutional/hospital products.

Typical professional specialties: Physicians, pulmonologists, infectious-disease specialists, hospital clinicians and critical-care teams.

Composition

Each 100 ml contains:

Moxifloxacin Hydrochloride equivalent to Moxifloxacin – 400 mg

Dosage form: Intravenous infusion
Concentration: 400 mg/100 ml / 0.4% w/v
Container: Single-dose container
Route: Intravenous use only

Indications / Uses

Moxifloxacin is used for susceptible bacterial infections when its use is clinically appropriate. Depending on locally approved prescribing information, these can include selected:

* Community-acquired bacterial pneumonia
* Complicated skin and skin-structure infections
* Complicated intra-abdominal infections
* Other susceptible bacterial infections for which moxifloxacin is specifically indicated

The precise indications of the marketed product should match its current approved Indian prescribing information.

Moxifloxacin does not treat viral infections such as the common cold or influenza.

Mechanism of Action – Step by Step

Step 1 – Moxifloxacin Reaches Susceptible Bacteria

Following IV administration, moxifloxacin reaches systemic circulation and distributes to tissues.

Step 2 – Targets Bacterial Enzymes

Moxifloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV.

Step 3 – DNA Processing Is Disrupted

These enzymes are essential for bacterial DNA replication, transcription, repair and recombination.

Step 4 – Bacterial Replication Is Inhibited

Disruption of these processes prevents susceptible bacteria from maintaining and replicating their genetic material.

Step 5 – Bactericidal Activity

The resulting DNA damage contributes to bacterial cell death.

Key Product Features

Moxibate offers:

* Moxifloxacin 400 mg/100 ml
* Fluoroquinolone antibacterial therapy
* Ready-to-use IV formulation
* Single-dose 100 ml container
* Intravenous administration
* Hospital/clinical-use presentation
* Broad antibacterial activity against susceptible organisms
* Intra Life anti-infective portfolio

Avoid marketing language such as “strongest antibiotic,” “guaranteed infection cure,” or claims that it works against every bacterial infection.

Dosage & Administration

For professional medical use only.

For adults for whom IV moxifloxacin is appropriately prescribed, 400 mg once every 24 hours is a commonly approved regimen for several indications. However, the indication, duration, route and suitability must be determined by the treating physician and the product’s approved prescribing information.

Moxifloxacin IV is administered as an intravenous infusion rather than a rapid IV injection/bolus.

Treatment duration varies depending on the infection and clinical response. Patients should not initiate, discontinue or switch antibiotics without medical direction.

Professional Usage Guide

Step 1: Confirm that the suspected or documented bacterial infection is an appropriate indication for moxifloxacin.

Step 2: Review relevant patient factors, allergies, concomitant medicines and clinical risks.

Step 3: Inspect the solution and container according to the product instructions.

Step 4: Administer intravenously according to the approved prescribing information and institutional protocol.

Step 5: Monitor clinical response and relevant adverse effects.

Step 6: Reassess antibiotic therapy when microbiological results become available and follow antimicrobial-stewardship principles.

 This product should be administered by trained healthcare professionals.

Important Safety Information

Fluoroquinolones, including moxifloxacin, have clinically important safety considerations. Depending on the patient, these may include risks involving tendons, peripheral nerves, central nervous system effects, QT prolongation/cardiac rhythm, blood-glucose disturbances and serious hypersensitivity reactions, among others.

Extra assessment may be required in patients with relevant cardiac risk factors or medicines that can prolong the QT interval.

The full approved prescribing information should be reviewed before use.

Packing Information

Brand: Moxibate Infusion
Generic: Moxifloxacin Hydrochloride Infusion
Strength: 400 mg/100 ml
Concentration: 0.4% w/v
Pack: 100 ml
Presentation: Single-dose container
Route: IV infusion only
Company: Intra Life
 

Frequently asked questions:

What is Moxibate Infusion?

Moxibate is an Intra Life prescription product containing Moxifloxacin 400 mg/100 ml for intravenous infusion.

Which drug class does Moxibate belong to?

Moxibate belongs to the fluoroquinolone antibacterial/antibiotic class.

How does Moxifloxacin work?

Moxifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, interfering with DNA replication and producing bactericidal activity against susceptible bacteria.

Is Moxifloxacin an antibiotic?

Yes. Moxifloxacin is a fluoroquinolone antibacterial medicine.

Is Moxibate used for viral infections?

No. Antibiotics such as moxifloxacin do not treat viral infections such as influenza or the common cold.

What is the strength of Moxibate?

The supplied product contains Moxifloxacin 400 mg in 100 ml (0.4% w/v).

Can Moxibate be self-administered?

No. It is an intravenous prescription antibiotic intended for administration under professional medical supervision.
 

Keywords